Our Faculty

Craig Okada
Assistant Professor of Medicine

Specialty: Hematology and Lymphoma

Clinic Phone: 503-494-6594
E-mail: okadac@ohsu.edu

Dr. Okada received his M.D. degree and Ph.D. degree in Cancer Biology at Stanford University School of Medicine in Palo Alto, CA. He continued his training at Stanford University with an Internal Medicine residency and Hematology fellowship. While at Stanford University, Dr. Okada conducted research in Immunology and Cancer Immunotherapy. He was a faculty member in Hematology/Oncology at the University of Michigan faculty and Staff Physician at the Ann Arbor VA in 1998-2004. While at University of Michigan, he was the co-director of the Cutaneous T cell Lymphoma Clinic and participated in Multidisciplinary Lymphoma Clinic. He joined the faculty at OHSU in 2004 where he continues to see patients with T cell lymphoma. His laboratory research is directed at developing cancer vaccine for lymphoma. Dr. Okada also sees hematology patients at the Portland Veteran's Affairs Medical Center.

• Okada CY, Wong CP, Denney DW and Levy R. T cell antigen receptor vaccines for active immunotherapy of T cell malignancies. J. Immun. (1997) 159:5516-5527.
• Wong CP, Okada, CY and Levy R. TCR vaccines against T cell lymphoma: QS-21 and IL-4 adjuvants induce a protective CD8+ T cell response. J. Immun. (1999) 162:2251-2258.
• Reddy SA. Okada C, Wong C, Bahler D, Levy R. T cell antigen receptor vaccines for active therapy of T cell malignancies. Annals of the New York Academy of Sciences (2001) 941:97-105.
• Gatza E and Okada CY. Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma. J. Immun. (2002) 169:5227-5235
• Lambert, SL, Okada CY, Levy R. TCR vaccines against a murine T cell lymphoma: A primary role for antibodies of the IgG2c class in tumor protection. J. Immunol. (2004) 172:929-936

Search PubMed for more publications